| Agricultural biotechnology (15) |  |
| Biotechnology (154) | |
| Agricultural biotechnology (15) | |
| Biotechnology (154) | |
The shortcoming of patents is that completely new fields of technology like biotechnology and software at first triggered off discussions about their patentability,
like in biotechnology. However, the proved link between science and technology, on the one hand, and changes in existing regulations or new regulations, on the other hand, underlines that the former can in general be used to determine possible challenges for the regulatory framework in the future.
biotechnology and material sectors 1. The forces impelling convergence at the time are seen as radical, revolutionary,
1. Life sciences and biotechnology 2. Information and communication technology 3. Materials and their production processes 4. Nanotechnology 5. Optics/photonics/optoelectronics 6. Industrial production processes
1) biotechnology and chemistry,(2) energy,(3) environment,(4) nanotechnology,(5) production and materials technology,(6) information systems,(7) simulation and, finally,(8) research consortia.
governance, transparency and biotechnology. Health, Risk and Society 4: 259 72. Brown, N, . and M. Michael. 2003.
as shown by recent biotechnology, can remain for a long period, driving to very different conditions under
/Futures 43 (2011) 232 242 236 For instance, the progressive sliding of the field of biocatalysis away from‘catalysis'within chemistry towards biotechnologies illustrates an actual reconfiguration of a current knowledge area that is combining splitting and merging
and biotechnology that was initiated by the European commission in 2003. It has produced a 20-year vision and a short,
Under pressure from the biotech firms, and from America and other big growers ofgmcrops, the EU then persuaded the anti-GM countries to replace the moratorium with a scheme in
microelectronics, materials and biotechnologies and as their‘bottom-up'convergence at the nanoscale. To address field specificities for Nanosciences and Nanotechnologies,
Biotechnology and nanotechnology topics are continuing players in the abstract sets. Synthetic biology the prospect of engineering cellular processes to operate as bioreactors, labs in a cell,
Typical lists that emerge are at a high level of aggregation (ICT, biotechnology, nanotechnology, etc. or at one level down listing around 100 key technologies.
effects of implementing the science policy priority for biotechnology in The netherlands, Research policy 15 (1986) 253 268.16 R. Coombs, L. Georghiou, A new industrial ecology, Science 296 (2002
1. Rapid and accelerating technological progress in pervasive fields such as microelectronics, ICTS, biotechnology, new materials, fuel cells and nanotechnologies. 2. Increased financial, trade and investment
rapid progress of ICT and biotech End of Moore's Law 100 years life expectancy Environment:
, interrestrial visitors, alliance, eco-collapse, biotech Increased impact of converging technologies on social life Natural language codifications becomes available allowing people communicate globally New s&t paradigms for knowledge society
‘‘Lag of the real behind the virtual''Biotech revolution and robotics change human race Less usage of human brain Freedom to do any type of Research breakthrough in plant gene to create antibiotics for cancer Nano membranes allow humans swim under water without air tubes Researchers
Earlier examples are biotechnology, genomics and microelectronics, or, more general, ICT. The media tell us
and technology (including biotechnology, neuroscience, artificial intelligence, genetics and genomics, digital environments, ambient intelligence), data protection and privacy law, intellectual property, philosophy of law and legal theory.
energy technologies or information and communication up to biotechnologies without their interdependence being always obvious at first glance.
driven by the confluence of nanotechnology, biotechnology and materials science (Linstone 2011a, 2011b. It is these fundamental changes that give rise to the main challenges of today'sworld.
Throughout publications about or adjacent to the nano-artefact, biotechnology, information technology and cognitive science quartet (NBIC), there is a continual introduction of ideas,
Brown and Michael (2003) describe the phenomenon of the trough of uncertainty in the study of clinical applications of biotechnology:
Promises of a better future in biotechnology advertisements. Science as Culture 11, no. 4: 459 79.
Today's NESTS are more apt for incorporating science-based advances (e g. biotechnologies and nanotechnologies),
Converging technologies, collaboration or fusion of several fields (nanotechnology, biotechnology, information technology, and cognitive science) have been given attention since the mid-2000s.
15 Biotechnology 16 Pharmaceuticals 17 Macromolecular chemistry, polymers 18 Food chemistry 19 Basic materials chemistry 20 Materials,
12 (Control), 15 (Biotechnology), 17 (Macromolecular chemistry, polymers), 19 (Basic materials chemistry), 20 (Materials, metallurgy), 23 (Chemical engineering), 24 (Environmental technology
where the possible source technologies comprise technologies 14 (Organic fine chemistry), 15 (Biotechnology), 23 (Chemical engineering), 24 (Environmental technology), 30 (Thermal processes and apparatus), 32
technology 15 (Biotechnology) to technology 1 Figure 2 Summary result of the mapping in three countries PAGE 62 jforesight jvol. 15 NO. 1 2013 (Electrical machinery
cooling cogeneration/building use 15 (Biotechnology) 1 (Electrical machinery, apparatus, energy) Japan Artificial photosynthesis technology/solar energy conversion efficiency;
The source technologies comprise technologies 12 (Control), 15 (Biotechnology), 17 (Macromolecular chemistry, polymers), 19 (Basic materials chemistry), 20 (Materials, metallurgy), 24 (Environmental
apparatus, energy) receives technologies from technologies 12 (Control), 15 (Biotechnology), 23 (Chemical engineering), 27 (Engines, pumps, turbines), 30 (Thermal processes and apparatus), 31 (Transport
the source technologies include technology 15 (Biotechnology), 23 (Chemical engineering), 24 (Environmental technology), 30 (Thermal processes and apparatus), 32 (Transport) and 35 Figure 3 Technology
Source technologies comprise technologies 7 (IT methods for management), 12 (Control), 15 (Biotechnology), 17 (Macromolecular chemistry
The possible source technologies comprise technologies 12 (Control), 15 (Biotechnology), 25 (Handling) and 27 (Engines, pumps, turbines;
The important source technologies comprise technologies 15 (Biotechnology), 17 (Macromolecular chemistry, polymers), 19 (Basic materials chemistry), 24 (Environmental technology) and 35 (Civil engineering.
Clearly, different types of technologies may have different developing patterns, especially for those technologies close to basic science, such as biotechnology,
it involves nanotechnology and biotechnology, with diverse application possibilities. Different types of technologies may have different developing patterns, especially for those technologies close to basic science, such as biotechnology.
Future research should also take this into account. Third, the classifier we used in this paper is the nearest neighbour classifier.
ethics and sustainability, of emerging technologies mainly inside agriculture, food production, biotechnology and bioenergy. Furthermore, he is an expert in foresight and scenario methodologies,
referring to the synergistic combination of nanotechnology, biotechnology, information technology and cognitive sciences (NBIC), where a similar governance framework as in the case of nanotechnology is discussed 10 (M. Roco, Possibilities for global governance of converging technologies, J. Nanopart.
It has been proposed that a new paradigm is develoopin in the 21st century based on the combinatiio of nanotechnology, biotechnology,
He took part in developiin the roadmap for Thailand's first biotechnology policy framework. He is currently the executive director of the APEC Center for Technology foresight and the director of Policy Research and Management at the National science Technology and Innovation policy Office, Bangkok,
National Center for Genetic engineering and Biotechnology. Roco, M C and W s Bainbridge, 2002. Converging technologies for Improving Human Performance:
So-called futureorieente technologies such as biotechnology (3. 6%of projects, 4. 5%of subsidies) and nanotechnology (5. 7%of projects, 3. 8%of subsidies) do not seem to have been promoted particularly.
discussion and prioritization of results in an integrated format Analyses of recommendations of each panel compared to previous Brazilian foresight studies and international information Final report and dissemination of results Biotechnology Mapping
and IPR as applied to biotechnology development Validation of results in workshoops final report and disseminnatio of results Nanotechnology Mapping current situation and future trends in S&t in Brazil and in a number of selected nations,
The case of Taiwanese pharmaceutical biotechnology and agricultural biotechnology innovation systems (1945 2000) Chao-chen Chung1 1manchester Business school, University of Manchester, Manchester, M13 9pl, UK.
Through comparing the Taiwanese pharmaceutical biotechnology and agricultural biotechnology innovation systems we find that even within the same nation different NSTISS reveal different dynamics, in terms of actors and networks, the application of technology and knowledge and institutions.
biotechnology; pharmaceuticals; agriculture. 1. Introduction Over the last two decades scholars working on innovattio systems have established different ways in
The Taiwanese biotechnology industry and the two sectors which adopt biotechnology (i e. pharmaceuticals and agriculture) provide an interesting case for our discussiion Historical records for the period 1945 2000 in Taiwan clearly show the process through which the three innovation systems,
and the technological innovation system for biotechnology, gradually configured each other. Indeed, the pharmaceutical and the agricultural sectors not only possessed contrasting opportunities for the development of biotechnology,
but were shaped extensively by different national institutions. The pharmaceuttica sector, which was composed mainly of local enterpriises that were small-and medium-sized enterprises (SMES), only adopted biotechnology after the 1980s.
The Taiwanese government shaped the sector through its policies on pharmaceuticals and biotechnology. On the other hand, the agricultural sector,
which was dominated by public research organizations, started to adopt biotechnollog before 1945. The Taiwanese government supported the sector through agricultural policies,
which were considered not part of the biotechnology policies. In summary within the same national border of Taiwan differren configurations of the three innovation systems show different dynamics,
Section 3 analyzes the evolution of the Taiwanese innovation systems for biotechnology, pharmaceuticals and agriculture through the lens of the configuration of the three innovation systems.
We choose the Taiwanese biotechnology and two biotechnology-related sectors as an empirical case because that case is discussed seldom in the existing literatuure Modern biotechnology,
as defined by Laage-Hellman et al. 2004), is developed the biotechnology in the post-genetic engineering era in the 1970s
and comprised of a broad range of knowledge fields. 1 The biotechnology developed before the post-genetic engineering era is defined in this paper as traditional biotechnology.
While the majority of the existing literature on modern biotechnollog focuses on the empirical experiences of European countries and the USA (Mckelvey et al. 2004;
Boschert and Gill 2005), only a few papers discuss the develoopmen of biotechnology (both traditional and modern) in Taiwan (Dodgson et al. 2008;
Indeed, the existing literature considers Taiwanese biotechnology to be a‘new sector 'which has emerged only in the last ten years
Nevertheless, as we will show in Section 3, Taiwan adopted traditional biotechnology before 1945 and adopted modern biotechnology as early as the 1980s.
Biotechnology is not a sector but a technology which is adopted by at least two sectors in Taiwan,
the Taiwanese government has implemented not a‘set of policies'towards biotechnology, but has adopted different sets of policies towards pharmaceuttica biotechnology and agricultural biotechnology.
The evolution of biotechnology and the two sectors before 2000 in fact deeply influences the development after 2000.
Since the history of biotechnology and the two sectors in Taiwan is missing, we select Taiwan as our empirical case and focus on the development in the period 1945 2000.
By analyzing the historical archives, such as government documents and the historical records of the institutions embedded in the innovation systems,
we will discover how the technological innovattio system for biotechnology gradually emerged with the Taiwanese national innovation system,
Taiwan. 273 3. The Taiwanese pharmaceutical biotechnology and agricultural biotechnology innovation systems This section analyzes the history of biotechnology and the two sectors in Taiwan through the lens of the NSTIS.
The Taiwanese government announced its first biotechnology policy, the‘Eight Key Industries'in 1982. After 1982, Taiwan started to have a biotechnology policy.
We discuss the evolution of the pharmaceutical biotechnology innovation system in Section 3. 1 and the evolution of the agricultural biotechnology innovation system in Section 3. 2. 3. 1 The evolution of the Taiwanese pharmaceutical biotechnology innovation system
3. 1. 1 Pharmaceutical companies: networks and knowledge base. Pharmaceutical technology was introduced originalll to Taiwan by Japan.
The knowledge base of all these firms was chemical engineerrin rather than biotechnology. Even if modern biotechnollog was developed in the USA in the 1970s,
these companies did not adopt any modern biotechnology in their products. In 1982, to fit the new‘Good Manufacturing Practice'regulations announced by the government,
) Only after the 1980s, was modern biotechnology graduaall adopted by the companies producing Chinese herbal medicines.
Modern biotechnology was applied to extract the functional ingredients of the herbs. Furthermore, modern biochemistry, which was introduced by scientists trained in the USA,
Modern biotechnology was introduced to Taiwan's universities in the 1980s by a group of young scientists.
These young scientists transferred modern pharmaceutical biotechnology, such as molecular biotechnology and biochemistry, from the universities of the USA to Taiwan and soon became the leaders of the pharmaceutical colleges.
Because of the particippatio of these young scientists, modern biotechnology was dispersed quickly among the universities and extensivvel deepened the level of pharmaceutical research for small molecular medicines and Chinese herbal medicines (Zheng,
2001: 242. Nevertheless, from the 1980s until 2000, the networks between the researchers and between universities and pharmaceutical companies were established not fully.
Since the universities were supposed not to directly interact with firms, the Development Centre of Biotechnology (DCB),
which could transfer pharmaceutical biotechnology from the universities to pharmaceutical companies. 3. 1. 3 National institutions:
Pharmaceutical and biotechnology policies. The Taiwanese government did not strategically promote a‘set of consistent policies'to foster the development of pharmaceutical biotechnologgy Instead,
each policy directed towards pharmaceutical biotechnology had its own historical background and changed with the evolution of pharmaceuticals and biotechnnology The Eight Key Industries policy,
which was the first biotechnology policy announced in 1982, should be regarded as an important milestone in the change of policies.
Besides recognizing biotechnology as one of the eight key industries in which the government should invest more resourrces there was no other concrete policy promoted under the framework of the Eight Key Industries.
Furthermore, according to the Eight Key Industries policy, the development of biotechnology was almost equal to the development of the pharmaceutical sector
whose knowledge base was chemical engineering rather than biotechnology (MOEA 2010). Policies of regulation, FDI and R&d were directed towards the pharmaceutical biotechnology innovation system.
The Law of Pharmaceutical Affairs was passed in 1970 and remained the most important regulation controlling the manufacture of medicines until 2000.
However, there was no R&d policy to encourage universities to transfer pharmaceuttica biotechnology to companies, and before the late 1990s, there was no particular target for the funding of R&d policies.
before the late 1990s, the government did not have specific policies to encourage the development of modern pharmaceutical biotechnology.
The Ass research organizations used the traditional biotechnology of hybridization to improve the genes of Japanese rice with the genes of Japonica, a Taiwanese rice
However, the introduction of modern biotechnology in the 1980s extensively changed the knowledge and technology used for seed innovation.
The modern biotechnology of genetic modification was introduced to the ASS through a group of Taiwanese scienttist who were trained in the USA.
While the traditional biotechnology of hybridization was retained for the innovattio of seeds and expanded to the innovation of new species of livestock, such as farm animals and aquaculture,
The technology used by these private companies was the traditional biotechnology of hybridizatiio which was used also by the ASS.
Through the flow of personneel knowledge of the traditional biotechnology of hybridizaatio was transferred between the university and the ASS.
) A group of Taiwanese scientists trained in US universities introduced modern molecular biotechnology to Taiwanese universities in the 1980s.
Until 2000, most results of modern biotechnology research done by the universities were transferred to the ASS for further application (Su 2004:
) Indeed, until the 1990s, the modern biotechnology innovated by the universities was transferred only occasionally to particular agricultural companies, such as Taikong. 3. 2. 3 National institutions:
The Taiwanese government supported the development of agriculttura biotechnology through its agricultural policies. The purpose of these policies changed dramatically in the 1980s.
when the first biotechnology policy, the Eight Key Industries, was announced in 1982, agricultural biotechnology was recognized not as a part of the development of biotechnologgy Indeed,
The two main agricultural policies promoting agricultuura biotechnology innovation system were agricultural R&d and regulation policies.
Before the 1980s, research into traditional biotechnology was funded in order to increase the productivity of the agricultural sector,
and after the 1980s, research in modern biotechnology was funded merely to increase the farmers'welfare (Chang 2004:
due to the governmment'policies, these biotechnologies were commercialized seldom. 4. Discussion and conclusion The Taiwanese pharmaceutical biotechnology innovation system and agricultural biotechnology innovation system reveal different dynamics.
The three innovation systems, i e. the Taiwanese national innovation system, the two sectoral systems of pharmaceuticals and agriculture,
and the technological innovation system for biotechnology, were configured differently. Different NSTISS not only had different components, but also evolved differently.
in the pharmaceuticca biotechnology innovation system local SMES led the innovation and manufacturing. MNCS were involved only once in the manufacturing activities of the system
However, in the agricultuura biotechnology innovation system the public research organizations, the ASS, were the foundations on
Only in the 1990s did some universities occasionally transfer modern biotechnology to agricultural SMES. In brief, within the same nation different NSTISS may involve different groups of actors
The system only adopted modern biotechnology and did not produce any opportunities for the development of traditional biotechnollogy Modern biotechnology was introduced only to the system after the 1980s
and was used to extract and analyze the medical ingredients of herbs. Modern biotechnology was integrated with the traditional Chinese knowledge of herbal medicine to produce new herbaceous medicines.
In contrast, in the agricultural biotechnology system both the public research organizations and private SMES adopted biotechnology as their main knowledge base.
The system provided the chance for the development of both traditional and modern biotechnology. The traditiiona biotechnology of hybridization had already been used before 1945
in order to improve the genes of rice and subtropical vegetables and fruits. Since the 1980s the modern technique of genetic modification was applied to improve the genes of subtropical fruits (such as papayas) and non-edible organisms (such as ornamental fish.
In summary, the two NSTISS in Taiwan used different processes to adopt biotechnology and produced different sets of products.
Thirdly, the national institutions which shape various NSTISS may differ and may each have a characteristic path of co-evolution with the NSTIS.
The policies directed towards the pharmaceutical biotechnology system were regulations, FDI and R&d. Before the 1980s,
when the pharmaceutical companies graduaall adopted biotechnology to innovate new herbaceous medicines, R&d policies became more and more importannt Indeed, the Eight Key Industries,
the first biotechnoloog policy, targeted the development of the pharmaceutical sector, rather than biotechnology. Whilst the public organizations such as the DCB transferred technologies to pharmaceutical companies,
they supported pharmaceutical companies to adopt more chemical engineerrin rather than biotechnology. On the other hand the agricultural biotechnology system was supported only by agricultural policies.
Even though the system certainly adopted biotechnnolog for innovation, the commercialization of agriculttura biotechnology was encouraged not by policies.
In the case of biotechnollogy a government should have different sets of policies for the development of pharmaceutical biotechnology and agricultural biotechnology.
DNA (the coding), proteins and molecules, cell and tissue culture and engineeering process biotechnology, and sub-cellular organnism (Laage-Hellman et al. 2004).
2. The medical device sector also adopts biotechnology through the development of bio-chips whose knowleedg base is across electronic engineering and biotechnollog (Dr. Chip 2010).
Boschert, K. and Gill, B. 2005)‘ Germany's agri-biotechnology policy: Precaution for choice and alternatives',Science and Public policy, 32: 285 92.
and measuring modern biotechnology'.'In: Laage-Hellman, J.,Rickne, A. and Mckelvey, M. eds. The Economic Dynamics of Modern Biotechnology, pp. 20 42.
Cheltenham: Edward Elgar. Cai, H.-Q. 2007) The King of watermelon: the story of Wen-Yu, Chen(:.
Development Center of Biotechnology. DCB (2004) The Yearbook of Chinese Herbal Medicine Industry 2004. Taipei:
Development Center of Biotechnology. Ding, Y.-X. 2001)‘ The history, current condition and future of pharmaceutical industry('.
the case of biotechnology innovation networks',Research policy, 37: 430 45. Dr. Chip. 2010), Products. Dr. Chip:<
Giesecke, S. 2000)‘ The contrasting roles of government in the development of biotechnology industry in the US and Germany',Research policy, 29: 205 23.
The Economic Dynamics of Modern Biotechnology, p. 319. Cheltenham: Edward Elgar. Lee, S.-J. and Hua, J. 2004)‘ The economic evaluation of the food industry using biotechnology'(.
'Taipeij: Food Industry Research and development Institute. Lin, J.-Y. 1995)‘ The experiments and research of Taiwan's Agriculture Experiment Station within recent one hundred years'(.
The Business of Biotechnology. Oxford: OUP. Mckelvey, M.,Orsenigo, L. and Pammolli, F. 2004)‘ Pharmaceutical analyzed through the lens of a sectoral innovaatio system'.
Taiwan's Biotechnology Policy and Promotion Status. Biotechnology & Pharmaceutical industries Program Office<http://www. bpipo. org. tw/en/policy. html>accessed 14 december 2010.
Paris. Senker, J. 2004)‘ An overview of biotechnology in Europe: firms, demand, government policy and research'.
The Economic Dynamics of Modern Biotechnology, pp. 99 134. Cheltenham: Edward Elgar. Science and Technology research and Information Center (2005)‘ Strategic planning on the development of Taiwan agricultural biotechnology industry'(.
The challenges of biotechnology',International Political science Review, 26: 169 91. Wong, J.-W. 1998)‘ The relationship between bureaucratic organizzatio and agricultural innovation:
Similarly, in many respects, breakthrough technologies due to developments in information and communiccatio technologies and nano-and biotechnologies have disruptive impacts on economies, markets and innovative consumer goods and services.
2 Food, Agriculture and Fisheries, and Biotechnology'.'Brussels: European commission. ERAC-GPC. 2011)‘ Voluntary Guidelines on Framework Conditions for Joint Programming in Research 2010'.
The cases of agri-biotechnology and mobile phoning',Science Technology and Human Values, 35: 783 811.
< Back - Next >
Overtext Web Module V3.0 Alpha
Copyright Semantic-Knowledge, 1994-2011